Rosen, global investor counsel, encourages nrx pharmaceuticals, inc. investors with losses to secure counsel before important deadline in securities class action - nrxp; nrxpw

New york, march 5, 2022 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of the securities of nrx pharmaceuticals, inc. (nasdaq: nrxp; nrxpw) between june 1, 2021 and november 4, 2021, inclusive (the "class period"), of the important march 21, 2022 lead plaintiff deadline. so what: if you purchased nrx securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NRXP Ratings Summary
NRXP Quant Ranking